NeuroVive Pharmaceutical AB EV/EBIT
¿Qué es el EV/EBIT de NeuroVive Pharmaceutical AB?
El EV/EBIT de NeuroVive Pharmaceutical AB es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en OTC en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con ev/ebit similar a NeuroVive Pharmaceutical AB
- ThermoGenesis Inc tiene EV/EBIT de N/A
- Touchpoint tiene EV/EBIT de N/A
- Amati AIM VCT plc tiene EV/EBIT de N/A
- Lilis tiene EV/EBIT de N/A
- GoldHaven Resources tiene EV/EBIT de N/A
- Nanostring Technologies Inc tiene EV/EBIT de N/A
- NeuroVive Pharmaceutical AB tiene EV/EBIT de N/A
- CE Brands tiene EV/EBIT de N/A
- Aquarius AI tiene EV/EBIT de N/A
- Tetra Bio-Pharma tiene EV/EBIT de N/A
- Luduson G tiene EV/EBIT de N/A
- Edenville Plc tiene EV/EBIT de N/A
- Chicken Soup for the Soul Entertainment Inc tiene EV/EBIT de N/A